The Global Breast Lesion Localization Methods Market Size accounted for USD 1.3 Billion in 2021 and is projected to achieve a market size of USD 4.1 Billion by 2030 rising at a CAGR of 13.8% from 2022 to 2030. Rising number of government and non-government repayment policies for the breast cancer diagnostics, biopsy, inspection, and other medical processes are projected to raise the acceptance of breast lesion localization methods.
Breast Lesion Localization Methods Market Report Statistics
- Global breast lesion localization methods market revenue is estimated to reach USD 4.1 Billion by 2030 with a CAGR of 13.8% from 2022 to 2030
- North America breast lesion localization methods market share accounted for over 36% shares in 2021
- According to the American Society of Clinical Oncology (ASCO), there are over 3.8 million women who have been diagnosed with breast cancer in the United States
- Asia-Pacific breast lesion localization methods market growth will register swift CAGR from 2022 to 2030
- Based on type, wire guided acquired over 40% of the overall market share in 2021
- Growing prevalence of breast cancer will fuel the global breast lesion localization methods market value
- Increasing demand for minimally invasive procedures is a popular breast lesion localization methods market trend that is fueling the industry demand
Global Breast Lesion Localization Methods Market Dynamics
Market Drivers
- Increasing incidences of breast cancer among women
- Surging awareness for cancer screening programs
- Rising preference for minimally invasive procedures
- Growing rate of aging population
Market Restraints
- Strict regulatory framework
- Risk related with breast localization methods
Market Opportunities
- Growing adoption of technologically advanced localization methods
- Increasing research on stem cell biology
Breast Lesion Localization Methods Market Report Coverage
Market |
Breast Lesion Localization Methods Market |
Breast Lesion Localization Methods Market Size 2021 |
USD 1.3 Billion |
Breast Lesion Localization Methods Market Forecast 2030 |
USD 4.1 Billion |
Breast Lesion Localization Methods Market CAGR During 2022 - 2030 |
13.8% |
Breast Lesion Localization Methods Market Analysis Period |
2018 - 2030 |
Breast Lesion Localization Methods Market Base Year |
2021 |
Breast Lesion Localization Methods Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Type, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
C.P. Medical, SOMATEX Medical Technologies GmbH, C.R. Bard, Argon Medical Devices, Inc., Cook Medical, Cianna Medical. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Breast Lesion Localization Methods Market Growth Factors
Breast cancer is the most noticeable and invasive cancers, therefore, growing occurrence of it among women is anticipated to boost the market development.
As per Breast Cancer Organization, it was estimated that in 2018, around 266,120 new cases of invasive and 63,960 cases of non-invasive breast cancer would be detected. Increasing numeral of government and non-government compensation policies for breast cancer diagnostics, biopsy, and other related medical processes is expected to drive the acceptance of breast lesion localization approaches.
Breast Lesion Localization Methods Market Insights
Increasing need for improved healthcare infrastructure and facilities and growing consciousness level about breast cancer screening are also estimated to drive the market development. Such as, national breast cancer screening program in Australia named the Breast Screen Australia that delivers free mammogram test services every 2 years for women aged between fifty and seventy four. Emerging regions, for instance, China and India are also increasing consciousness about early analysis.
Breast Lesion Localization Methods Market Segmentation
The global breast lesion localization methods market is segmented based on type, and geography.
Breast Lesion Localization Methods Market By Type
- Wire Guided
- Radioisotope
- Radio Guided Occult-Lesion Localization (ROLL)
- Radioactive-Seed Localization (RSL)
- Others
- Magnetic Tracer
- Others
According to our industry analysis of breast lesion localization methods, the wire localization segment gained a significant market share throughout the projected timeframe. The demand for this segment is being driven by factors such as its accuracy in minimal removal of normal tissues, abnormal tissue localization, minimal scarring, and the availability of reimbursement for breast lesion localization devices.
Breast Lesion Localization Methods Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Breast Lesion Localization Methods Market Regional Analysis
North America captures the largest regional market and captured for 36.0% of the global market in 2018. The occurrence of well-established healthcare infrastructure and key producers in U.S. is anticipated to increase the regional development. Technological progressions paired with high economic growth in this region are also likely to boost the market.
Also, numerous activities by government and private firms to surge the consciousness is anticipated to spur the region’s growth. Such as, Wacoal America, Inc. planned a fund-raising activity, “Fit for the Cure”. The main objective was to contribute the treasuries to Susan G. Komen Breast Cancer Foundation and concurrently spread breast cancer consciousness in U.S.
Asia Pacific is anticipated to register the fastest CAGR of 16.3% during the forecast period due to high-unmet clinical needs, increasing disposable income level and patient awareness about early diagnosis. Also, speedily emerging healthcare infrastructure and growing need for breast conserving surgery are expected to provide potential development platform for this region. The industry is also driven by parameters, for instance, growing medical tourism in developing nations of APAC.
Breast Lesion Localization Methods Market Players
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the breast lesion localization methods market are C.P. Medical, SOMATEX Medical Technologies GmbH, C.R. Bard, Argon Medical Devices, Inc., Cook Medical, Cianna Medical, and others.
CHAPTER 1. Industry Overview of Breast Lesion Localization Methods Market
1.1. Definition and Scope
1.1.1. Definition of Breast Lesion Localization Methods
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Breast Lesion Localization Methods Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Breast Lesion Localization Methods Market By Type
1.2.3. Breast Lesion Localization Methods Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Breast Lesion Localization Methods Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Breast Lesion Localization Methods Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Breast Lesion Localization Methods Market By Type
4.1. Introduction
4.2. Breast Lesion Localization Methods Revenue By Type
4.2.1. Breast Lesion Localization Methods Revenue (USD Billion) and Forecast, By Type, 2018-2030
4.2.2. Wire Guided
4.2.2.1. Wire Guided Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Radioisotope
4.2.3.1. Radioisotope Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.2. Radio Guided Occult-Lesion Localization (ROLL)
4.2.3.2.1. Radio Guided Occult-Lesion Localization (ROLL) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.3. Radioactive-Seed Localization (RSL)
4.2.3.3.1. Radioactive-Seed Localization (RSL) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.4. Others
4.2.3.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Magnetic Tracer
4.2.4.1. Magnetic Tracer Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.5. Others
4.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. North America Breast Lesion Localization Methods Market By Country
5.1. North America Breast Lesion Localization Methods Market Overview
5.2. U.S.
5.2.1. U.S. Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
5.3. Canada
5.3.1. Canada Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
5.4. North America PEST Analysis
CHAPTER 6. Europe Breast Lesion Localization Methods Market By Country
6.1. Europe Breast Lesion Localization Methods Market Overview
6.2. U.K.
6.2.1. U.K. Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
6.3. Germany
6.3.1. Germany Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
6.4. France
6.4.1. France Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
6.5. Spain
6.5.1. Spain Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
6.6. Rest of Europe
6.6.1. Rest of Europe Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
6.7. Europe PEST Analysis
CHAPTER 7. Asia Pacific Breast Lesion Localization Methods Market By Country
7.1. Asia Pacific Breast Lesion Localization Methods Market Overview
7.2. China
7.2.1. China Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
7.3. Japan
7.3.1. Japan Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
7.4. India
7.4.1. India Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
7.5. Australia
7.5.1. Australia Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
7.6. South Korea
7.6.1. South Korea Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
7.7. Rest of Asia-Pacific
7.7.1. Rest of Asia-Pacific Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
7.8. Asia Pacific PEST Analysis
CHAPTER 8. Latin America Breast Lesion Localization Methods Market By Country
8.1. Latin America Breast Lesion Localization Methods Market Overview
8.2. Brazil
8.2.1. Brazil Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
8.3. Mexico
8.3.1. Mexico Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
8.4. Rest of Latin America
8.4.1. Rest of Latin America Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
8.5. Latin America PEST Analysis
CHAPTER 9. Middle East & Africa Breast Lesion Localization Methods Market By Country
9.1. Middle East & Africa Breast Lesion Localization Methods Market Overview
9.2. GCC
9.2.1. GCC Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
9.3. South Africa
9.3.1. South Africa Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
9.4. Rest of Middle East & Africa
9.4.1. Rest of Middle East & Africa Breast Lesion Localization Methods Revenue (USD Billion) and Forecast By Type, 2018-2030
9.5. Middle East & Africa PEST Analysis
CHAPTER 10. Player Analysis Of Breast Lesion Localization Methods Market
10.1. Breast Lesion Localization Methods Market Company Share Analysis
10.2. Competition Matrix
10.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
10.2.2. New Product Launches and Product Enhancements
10.2.3. Mergers And Acquisition In Global Breast Lesion Localization Methods Market
10.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 11. Company Profile
11.1. C.P. Medical
11.1.1. Company Snapshot
11.1.2. Business Overview
11.1.3. Financial Overview
11.1.3.1. Revenue (USD Billion), 2021
11.1.3.2. C.P. Medical 2021 Breast Lesion Localization Methods Business Regional Distribution
11.1.4. Product /Service and Specification
11.1.5. Recent Developments & Business Strategy
11.2. SOMATEX Medical Technologies GmbH
11.3. C.R. Bard
11.4. Argon Medical Devices, Inc.,
11.5. Cook Medical
11.6. Cianna Medical